“…As hypothesized, a larger proportion of SGs predicted larger increases in BMI between baseline and 6, 12, and 24 months postrandomization. Importantly, there were no differences in BMI at baseline between those who did and did not experience SGs, suggesting that those experiencing SGs did not have a lower BMI at baseline and then regress towards the mean, as has been previously suggested (Konig, Karl, Rosner, & Butollo, ). However, it may not be surprising that individuals who experienced more SGs in BMI during treatment had larger increases in BMI between baseline and follow‐up, as SGs and outcomes were both measured from baseline, and therefore covered the same time period.…”